CAS No. : 1001404-83-6

Product Details
For research use only. Not Intended for Therapeutic Use!
Cat No:I000352
Synonyms:AAI-101; AAI-101; AAI-101;(2S,3S,5R)-3-methyl-3-((3-methyl-1H-1,2,3-triazol-3-ium-1-yl)methyl)-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate 4,4-dioxide
Molecular Formula:C11H14N4O5S
Molecular Weight:314.316
Target:Beta Lactamase Inhibitor
Price:Get quote
We would like to match the lowest price on market if possible.

Your information is safe with us.

Appearance:Solid powder
Purity: > 98%
Cat No:I000352
Cas No:1001404-83-6
AAI-101 is a beta lactamase inhibitor potentially for the treatment of multi-drug resistant gram-negative bacterial infections.

1: Crandon JL, Nicolau DP. In vivo activities of simulated human doses of cefepime and cefepime-AAI101 against multidrug-resistant Gram-negative Enterobacteriaceae. Antimicrob Agents Chemother. 2015 May;59(5):2688-94. doi: 10.1128/AAC.00033-15. PubMed PMID: 25712356; PubMed Central PMCID: PMC4394792.
2: Crandon JL, Nicolau DP. In Vitro Activity of Cefepime/AAI101 and Comparators against Cefepime Non-susceptible Enterobacteriaceae. Pathogens. 2015 Aug 18;4(3):620-5. doi: 10.3390/pathogens4030620. PubMed PMID: 26295262; PubMed Central PMCID: PMC4584277.
3: Bush K. A resurgence of β-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogens. Int J Antimicrob Agents. 2015 Nov;46(5):483-93. doi: 10.1016/j.ijantimicag.2015.08.011. Review. PubMed PMID: 26498989.
Recommended Products
  • CAS No. :114849-58-0
    Product Name:


    Cat No: M016543 View details
  • CAS No. :121246-91-1
    Product Name:


    Cat No: M016544 View details
  • CAS No. :117783-53-6
    Product Name:

    3/'-azido-2/',3/'-dideoxyuridine 5/'-monophosphate

    Cat No: M016545 View details
  • CAS No. :118684-58-5
    Product Name:

    Oxiranemethanol, 3-(1-pentynyl)-, (2S-trans)- (9CI)

    Cat No: M016546 View details